700 12th Street, NW, Suite 900
Washington, District Of Columbia 20005
Joy Liu advises drug, biotech, and device companies on a broad range of FDA regulatory matters. Joy has significant experience working on advertising and promotion compliance matters, Hatch-Waxman patent and exclusivity issues, and regulatory risk management. She has also worked on a number of government investigations, helping to defend companies during civil and criminal investigations concerning off-label promotion, recalls, safety reporting, and GMPs. In addition, Joy’s perspective is bolstered by her in-house counsel experience gained during an eight-month secondment to a multinational pharmaceutical company, where she worked as the sole product attorney for a $3 billion drug, sat on the copy review committee, and advised on fraud and abuse issues. Joy serves on the Board of Directors of the Food and Drug Law Institute and is a member of the Editorial Advisory Board for the Food and Drug Law Journal.
|Areas of Practice||1) Corporate, 2) Life Sciences, 3) Social Media and 4) FDA Regulatory|
|Law School||Columbia Law School (J.D. 2002)|
|Education||Harvard University (A.B., 1999)|
|Bar Member / Association||State Bar Of District of Columbia, State Bar Of Massachusetts|
|Most recent firm||Ropes & Gray LLP|
Alan Singer is a partner in Morgan Lewis's Securities Practice. Mr. Singer advises companies with regard to a diverse range of corporate and securities matters.